Evidence map›Paper›PMID 36214949›Full record

ArticleMolecular biology reports2022

A functional microRNA binding site variant in IL-23R gene in systemic lupus erythematosus and rheumatoid arthritis: is there any correlation?

Samira Alesaeidi, Saeed Esmaeili Dizghandi, Goli Siri, Meysam Mosallaei, Taiebe Kenarangi, Tahereh Ghorashi, Mohsen Soosanabadi

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Samira AlesaeidiRheumatology and Internal Medicine, Rheumatology Research Center, Amir-Alam Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Saeed Esmaeili DizghandiDepartment of Medical Genetics, Semnan University of Medical Sciences, Semnan, Iran.
Goli SiriDepartment of Internal Medicine, Amir-Alam Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Meysam MosallaeiDepartment of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Taiebe KenarangiStudent Research Committee, Faculty of Statistics, University of Social Welfare and Rehabilitation Science, Tehran, Iran.
Tahereh GhorashiDepartment of Medical Genetics, Semnan University of Medical Sciences, Semnan, Iran.
Mohsen SoosanabadiDepartment of Medical Genetics, Semnan University of Medical Sciences, Semnan, Iran. m_soosanabadi@yahoo.com.ORCID http://orcid.org/0000-0003-0186-9464
Semnan University of Medical Sciences · IRTehran University of Medical Sciences · IRIsfahan University of Medical Sciences · IRUniversity of Social Welfare and Rehabilitation Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIL-23 receptor (IL-23R) dysregulation has been shown to have critical roles in pathogenesis of different autoimmune diseases including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) via suppression of regulatory T cells (Tregs) as well as differentiation, expansion, and survival of T helper 17 (Th17) cells, followed by upregulation of interleukin 17 (IL-17). Here, we assessed the association of a functional microRNAs (miRNAs)-related single nucleotide polymorphism (miR-SNPs: rs10889677) in IL-23R, which was correlated with its overexpression and increased risk for SLE and RA in the Iranian population.

methodsGenotype and allele distribution of rs10889677 variant were investigated in 105 RA patients, 100 SLE cases and 105 healthy controls via polymerase chain reaction- restriction fragment length polymorphism (PCR-RFLP) method.

resultsOur findings suggested that AA genotype, but not AC genotype, was associated with increased risk of RA (AA vs. CC; OR: 3.27; 95%CI [1.467-7.551]). The allele A was more frequent in RA group compared to controls (A allele vs. C allele; OR: 1.92; 95%CI [1.282-2.894]). This common variant was not significantly correlated with SLE risk in our population (P > 0.05). However, stratification analysis indicated that RA patients with AA genotype show higher serum concentration levels of C-reactive protein (CRP) (P: 0.008). No obvious correlation was noticed between different genotypes in SLE cases, except for a slight difference in terms of oral ulcer manifestation incidence (P: 0.038).

conclusionThis study suggests a significant relationship between rs10889677 variant in IL-23R with increased risk of RA and some clinical features in RA and SLE patients.

Indexed as

Arthritis, RheumatoidLupus Erythematosus, SystemicMicroRNAsReceptors, InterleukinBinding SitesCase-Control StudiesGene FrequencyGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeHumansIranPolymorphism, Single NucleotideIL23R protein, humanMicroRNAsReceptors, InterleukinIL-23R geneRheumatoid arthritisSystemic lupus erythematosusVariant

Identifiers

PMID36214949
OpenAlexW4303985984

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.